Literature DB >> 15118291

Sinus node function in patients with Brugada-type ECG.

Hiroshi Morita1, Kengo Fukushima-Kusano, Satoshi Nagase, Kohei Miyaji, Shigeki Hiramatsu, Kimikazu Banba, Nobuhiro Nishii, Atsuyuki Watanabe, Mikio Kakishita, Shiho Takenaka-Morita, Kazufumi Nakamura, Hironori Saito, Tetsuro Emori, Tohru Ohe.   

Abstract

BACKGROUND: Some studies have shown that patients with Brugada syndrome (BS) have atrioventricular conduction disturbance, but their sinus node function has not been evaluated. METHODS AND
RESULTS: The patients group consisted of 59 male patients and 1 female patient with BS. Supraventricular and ventricular programmed electrical stimulation (PES) was performed. Ventricular fibrillation (VF) or sustained polymorphic ventricular tachycardia was induced by ventricular PES in 26 patients with BS (VF group), but was not induced in the other 34 patients (non-VF group). Sinus node function and conduction of the atrioventricular (AV) node in the control group, non-VF group and VF group were evaluated. Sinus node function was attenuated and the His - ventricle interval was prolonged in the VF group (corrected sinus node recovery time: 452+/-126 ms (VF group), 324+/-146 ms (non-VF group), Sino-atrial conduction time: 179+/-60 ms (VF group), 127+/-60 ms (non-VF group), His-ventricle interval: 41+/-9 ms (VF group), 35+/-8 ms (non-VF group)).
CONCLUSION: The function of both the sinus node and AV node are attenuated in patients with PES-induced VF.

Entities:  

Mesh:

Year:  2004        PMID: 15118291     DOI: 10.1253/circj.68.473

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  12 in total

1.  Brugada syndrome subject to depolarization abnormality of the conduction system.

Authors:  Yusuke Hosokawa; Norishige Morita; Michio Ogano; Hiroyuki Yokoyama
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-10       Impact factor: 1.468

2.  Multiple syncope mechanisms coexisting in a Brugada syndrome patient requiring a single therapeutic approach.

Authors:  A I Vouliotis; K A Gatzoulis; P Dilaveris; C Stefanadis
Journal:  Herz       Date:  2012-10-10       Impact factor: 1.443

3.  Brugada Syndrome: Defining the Risk in Asymptomatic Patients.

Authors:  Juan Sieira; Pedro Brugada
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

Review 4.  Therapy for the Brugada syndrome.

Authors:  C Antzelevitch; J M Fish
Journal:  Handb Exp Pharmacol       Date:  2006

Review 5.  Pathogenesis and management of Brugada syndrome.

Authors:  Juan Sieira; Gregory Dendramis; Pedro Brugada
Journal:  Nat Rev Cardiol       Date:  2016-09-15       Impact factor: 32.419

Review 6.  Risk stratification and treatment of brugada syndrome.

Authors:  Elena Arbelo; Josep Brugada
Journal:  Curr Cardiol Rep       Date:  2014-07       Impact factor: 2.931

Review 7.  Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.

Authors:  Charles Antzelevitch; Bence Patocskai
Journal:  Curr Probl Cardiol       Date:  2015-06-11       Impact factor: 5.200

8.  A Novel SCN5A Variant Causes Temperature-Sensitive Loss Of Function in a Family with Symptomatic Brugada Syndrome, Cardiac Conduction Disease, and Sick Sinus Syndrome.

Authors:  Karolina Sanner; Johanna Mueller-Leisse; Christos Zormpas; David Duncker; Andreas Leffler; Christian Veltmann
Journal:  Cardiology       Date:  2021-07-08       Impact factor: 1.869

Review 9.  Electrophysiological Mechanisms of Brugada Syndrome: Insights from Pre-clinical and Clinical Studies.

Authors:  Gary Tse; Tong Liu; Ka H C Li; Victoria Laxton; Yin W F Chan; Wendy Keung; Ronald A Li; Bryan P Yan
Journal:  Front Physiol       Date:  2016-10-18       Impact factor: 4.566

Review 10.  Brugada syndrome and sinus node dysfunction.

Authors:  Hidemori Hayashi; Masataka Sumiyoshi; Yuji Nakazato; Hiroyuki Daida
Journal:  J Arrhythm       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.